Natco Pharma Q1 net up 69.7 pc to Rs 47.65 crore

Shares of Natco Pharma ended 1.65 per cent down at Rs 625.80 on BSE

Last Updated : Aug 09 2016 | 4:37 PM IST

Natco Pharma reported 69.75 per cent increase in consolidated net profit to Rs 47.65 crore for the first quarter ended June 30, 2016.

The company had reported a net profit of Rs 28.07 crore for the April-June quarter of the last fiscal.

Its consolidated net sales were up 38.02 per cent to Rs 297.71 crore during the period under review as against Rs 215.69 crore in the corresponding quarter of previous fiscal, Natco Pharma informed BSE.

Meanwhile in a separate filing, Natco Pharma said that its board in a meeting held today recommended payment of an interim dividend of Rs 0.75 on each equity share of Rs 2 each for 2016-17.

Shares of Natco Pharma ended 1.65 per cent down at Rs 625.80 on BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Already subscribed? Log in

Subscribe to read the full story →

^*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

In-depth market analysis & insights with access to The Smart Investor

Ad-free Reading

Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

Access Business Standard across devices — mobile, tablet, or PC, via web or app

SAVE 25%

Subscribe for ₹2,700 / 1 Year

Connect with us on WhatsApp

Natco Pharma Q1 net up 69.7 pc to Rs 47.65 crore

Shares of Natco Pharma ended 1.65 per cent down at Rs 625.80 on BSE